Company / R&D Expense
Glucotrack, Inc. R&D Expense History
FY2014-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.6M
FY2020
5-year range
$1.6M / $3.2M
FY2016-FY2020
Trend
-47.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 7 years, ranging from $2M in FY2020 to $3M in FY2018.
Based on SEC 10-K filings.
$2M in FY2020 with a 5-year CAGR of -4.2%.
Declined from $3M to $2M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -10.9%
- 5-Year CAGR
- -4.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -4.2%, indicating a declining trend.
- In FY2020, r&d expense decreased 47.0% year-over-year.
- Peak r&d expense was recorded in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $1.6M | -47.0% |
| FY2019 | $3.0M | -5.4% |
| FY2018 | $3.2M | +41.4% |
| FY2017 | $2.3M | +22.6% |
| FY2016 | $1.8M | -6.9% |
| FY2015 | $2.0M | +3.4% |
| FY2014 | $1.9M | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026